ArticleInfection and drug resistance2019
Prevalence and molecular epidemiology characteristics of carbapenem-resistant
Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Detection of a genetically related carbapenemase-producing Escherichia coli ST167 in clinical and environmental isolates: Evidence for clonal spread of carbapenemase-producing Enterobacteriaceae in humans and the environment in Iowa, United States.Journal of global antimicrobial resistance · 2025Article
- Biological characterization of novelFrontiers in microbiology · 2025Article
- Low temperatures do not impair the bacterial plasmid conjugation on poultry meat.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Betaxolol as a Potent Inhibitor of NDM-1-PositiveInternational journal of molecular sciences · 2023Article
- Antimicrobial Resistance and Transconjugants Characteristics ofAnimals : an open access journal from MDPI · 2022Article
- Global Distribution of Extended Spectrum Cephalosporin and Carbapenem Resistance and Associated Resistance Markers inFrontiers in microbiology · 2022Review
- Bacterial Outer Membrane Permeability Increase Underlies the Bactericidal Effect of Fatty Acids FromFrontiers in microbiology · 2022Article
- ISmSystems · 2021Article
- Role of Plasmids in the Ecology and Evolution of "High-Risk" Extraintestinal PathogenicEcoSal Plus · 2021Review
- Clinical Distribution Characteristics of 1439 Carbapenem-ResistantInfection and drug resistance · 2021Article
- Temperature-Regulated IncX3 Plasmid Characteristics and the Role of Plasmid-Encoded H-NS in Thermoregulation.Frontiers in microbiology · 2021Article
- Prevalence of avian-origin mcr-1-positive Escherichia coli with a potential risk to humans in Tai'an, China.Poultry science · 2020Article
- Carbapenem-ResistantInfection and drug resistance · 2020Article
- NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.Infection and drug resistance · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis retrospective study was conducted to determine the prevalence and molecular epidemiology characteristics of carbapenem-resistant
methodsA total of 593
resultsFive NDM-1-positive
conclusionThe study revealed the early molecular epidemiology and dissemination characteristics of CRE. In addition, the overall antimicrobial resistance in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.